MARAVAI LIFESCIENCES HOLDINGS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.2 USD | +4.67% |
|
+26.27% | +70.99% |
Chart calendar Maravai LifeSciences Holdings, Inc.
6c211b2efc56b9.reW0NOV41-SV2sk_hPiTsSZJ5MEa6ONoAbHsL_uWxDI.1Yn6AbYzmtDCj5Bm3LrDwWUlkJEsvNVFcffbRbr9t0j5tNpjvRvk1Pm8kA~9ec5735994370bb8e73a6648f8c9cd32
Upcoming events on Maravai LifeSciences Holdings, Inc.
Past events on Maravai LifeSciences Holdings, Inc.
| 2024-05-15 03:35 pm | RBC Capital Markets Global Healthcare Conference |
| 2024-05-08 05:00 pm | Q1 2024 Earnings Call |
| 2024-05-08 04:05 pm | Q1 2024 Earnings Release |
| 2024-03-19 02:15 pm | KeyBanc Life Sciences & MedTech Forum |
| 2024-02-22 05:00 pm | Q4 2023 Earnings Call |
| 2024-02-22 04:05 pm | Q4 2023 Earnings Release |
| 2023-11-16 09:00 am | Jefferies London Healthcare Conference |
| 2023-11-07 05:00 pm | Q3 2023 Earnings Call |
| 2023-11-07 04:05 pm | Q3 2023 Earnings Release |
| 2023-09-28 10:00 am | R&D Day |
| 2023-08-16 05:00 pm | UBS MedTech Tools and Genomics Summit |
| 2023-08-07 05:00 pm | Q2 2023 Earnings Call |
| 2023-08-07 04:05 pm | Q2 2023 Earnings Release |
| 2023-05-18 05:30 pm | Annual General Meeting |
| 2023-05-08 05:00 pm | Q1 2023 Earnings Call |
| 2023-05-08 04:05 pm | Q1 2023 Earnings Release |
| 2023-03-27 | SVB Securities Foundations of Discovery Drugs and Dx Conference |
| 2023-03-21 12:45 pm | KeyBanc Life Sciences & MedTech Forum |
| 2023-03-15 05:00 pm | Barclays Global Healthcare Conference |
| 2023-02-22 05:00 pm | FY 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 284 275 3.21% | 799 779 2.58% | 883 883 -0.05% | 289 279 3.47% | 275 |
|
EBITDA Million USD | Released Forecast Spread | 169 147 14.95% | 583 571 2.1% | 638 651 -2.09% | 65,3 56,2 16.17% | 63,4 |
|
EBIT Million USD | Released Forecast Spread | 143 133 7.95% | 558 539 3.59% | 606 620 -2.2% | 25,1 18,8 33.58% | 18,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 81,7 99,1 -17.53% | 531 520 2.02% | 551 586 -5.93% | 618 -57,3 1177.74% | -65,2 |
|
Net income Million USD | Released Forecast Spread | 89,0 76,9 15.67% | 182 299 -39.14% | 220 269 -18.12% | -119 -26,4 -350.42% | -32,3 |
|
EPS USD | Released Forecast Spread | 0,35 0,31 12.53% | 1,56 1,24 25.77% | 1,67 1,27 31.95% | -0,90 -0,09 -872.97% | -0,22 |
| Announcement Date | 02/03/21 | 23/02/22 | 22/02/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 244 232 5.17% | 243 233 4.08% | 191 196 -2.23% | 205 205 -0.12% | 79,0 79,7 -0.88% | 68,9 71,1 -3.11% | 66,9 75,5 -11.46% | 74,1 64,3 15.23% | 64,2 60,5 6% | 71,3 | 68,3 | 71,6 | 71,5 | 74,2 |
|
EBITDA Million USD | Released Forecast Spread | 187 162 15.51% | 188 166 13.36% | 133 129 2.46% | 130 143 -9.48% | 23,8 26,2 -9.05% | 9,08 17,3 -47.56% | 11,9 15,4 -22.62% | 20,5 11,4 80.62% | 7,80 8,93 -12.68% | 17,4 | 17,3 | 20,4 | 16,2 | 19,0 |
|
EBIT Million USD | Released Forecast Spread | 180 156 15.4% | 180 158 14.29% | 124 119 4.94% | 122 135 -9.88% | 15,0 17,3 -13.48% | -0,59 7,02 -108.4% | 0,96 7,34 -86.93% | 9,73 1,33 630.28% | -3,86 -2,10 -83.81% | 8,43 | 5,72 | 8,30 | 6,67 | 9,60 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 167 149 12.1% | 175 152 15.48% | 114 106 7.63% | 95,9 122 -21.54% | -4,52 10,3 -144.11% | -13,4 0,90 -1580.55% | -20,6 -2,70 -660.96% | 656 -13,9 4820.76% | -22,4 -14,9 -50.26% | -11,0 | -11,4 | -8,00 | -16,4 | -15,0 |
|
Net income Million USD | Released Forecast Spread | 66,9 88,3 -24.3% | 71,2 90,1 -20.97% | 44,5 52,2 -14.81% | 37,6 61,2 -38.5% | -0,07 4,15 -101.61% | -6,54 0,51 -1371.92% | -6,46 -2,08 -211.28% | -106 -6,18 -1615.94% | -12,1 -8,01 -50.72% | -6,02 | -6,72 | -5,36 | -10,0 | -7,45 |
|
EPS USD | Released Forecast Spread | 0,50 0,39 26.88% | 0,53 0,38 40.37% | 0,34 0,29 16.26% | 0,28 0,27 3.5% | 0,00 0,02 - | -0,05 0,00 -2037.98% | -0,05 -0,01 -496.66% | -0,80 -0,02 -3329.06% | -0,09 -0,05 -85.11% | -0,04 | -0,05 | -0,03 | -0,08 | -0,06 |
| Announcement Date | 05/05/22 | 04/08/22 | 02/11/22 | 22/02/23 | 08/05/23 | 07/08/23 | 07/11/23 | 22/02/24 | 08/05/24 | - | - | - | - | - |
More events
Past sector events for Maravai LifeSciences Holdings, Inc.
| 2024-05-09 | SEEGENE, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | GUARDANT HEALTH, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:01 pm | IOVANCE BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-08 04:05 pm | MARAVAI LIFESCIENCES HOLDINGS, INC.: Q1 2024 Earnings Release |
| 2024-05-08 04:05 pm | EXACT SCIENCES CORPORATION: Q1 2024 Earnings Release |
| 2024-05-07 04:05 pm | VERACYTE, INC.: Q1 2024 Earnings Release |
| 2024-04-26 | BGI GENOMICS CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-12 | BGI GENOMICS CO., LTD.: Q4 2023 Earnings Release |
| 2024-02-28 04:05 pm | CAREDX, INC: Q4 2023 Earnings Release |
| 2024-02-28 04:01 pm | IOVANCE BIOTHERAPEUTICS, INC.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MRVI Stock
- Calendar Maravai LifeSciences Holdings, Inc.